Dutch Cabinet awards NGI EUR 271 million
Second phase Netherlands Genomics Initiative (NGI)
The Netherlands genomics Initiative (NGI) announce the decision of the Dutch cabinet to award NGI a second phase. The government will continue its investment in genomics by contributing EUR 271 million in the coming years. With this decision, the Dutch cabinet recognises the results of the NGI Genomics Centres during their first term, both scientifically and in terms of valorisation. The continuity that this decision provides for the most successful NGI Genomics Centres will ensure continued excellence in their performance, with an increased focus on valorisation.
High value for Dutch knowledge economy
This investment also underlines the importance that the Life Sciences sector, of which the Netherlands Genomics Initiative forms an integral part, has for the Dutch knowledge economy in general. The Dutch cabinet has already shown its commitment to the Life Sciences sector by investing in several important initiatives such as Technological Top Institutes (TTIs) and innovation programmes. With the continued support for NGI, the Dutch cabinet underscores that in fostering innovation it is vital to support both fundamental and more application oriented research programmes.
Maximizing economic and societal value
In its second term, NGI aims to maximize the economic and societal value of its scientific research. The Netherlands Genomics Initiative will set ambitious and quantitative scientific and valorisation targets. Furthermore, it aims to strengthen the valorisation infrastructure of its centres with a view to realising their ambitious valorisation targets.
Other news from the department politics & laws
